Results 41 to 50 of about 137,248 (208)

Drugs for discoid lupus erythematosus [PDF]

Cochrane Database of Systematic Reviews, 2000
Discoid lupus erythematosus is a chronic form of cutaneous (skin) lupus which can cause permanent scarring if treatment is inadequate. Many drugs have been used to treat this disease and some of these are potentially very toxic.To assess the effects of drugs for discoid lupus erythematosus.We searched the Cochrane Clinical Trials Register (December ...
Sue, Jessop, David A, Whitelaw, Finola M, Delamere   +2 more
openaire   +7 more sources

Grupos sanguíneos e lúpus eritematoso crônico discoide Blood groups and discoid lupus erythematosus

Anais Brasileiros de Dermatologia, 2009
FUNDAMENTOS: Lesão discoide é a manifestação cutânea mais comum do lúpus eritematoso, e formas cutâneas crônicas apresentam características imunológicas próprias, direcionadas ao polo Th1.
Andréia de Almeida Tamega, Lílian Valéria Guerra da Silva Pinto Bezerra, Fabíola de Paula Pereira, Hélio Amante Miot   +3 more
doaj   +1 more source

Pigmented linear discoid lupus erythematosus following the lines of Blaschko: A retrospective study of a Chinese series

Indian Journal of Dermatology, Venereology and Leprology, 2020
Background: Linear cutaneous lupus erythematosus is a rare subtype of lupus erythematosus (LE) that develops linear lesions following the lines of Blaschko.
Wei Liu, S. Vañó-Galván, Jia-Wei Liu, Yue-Tong Qian, K. Fang, D. Ma   +5 more
semanticscholar   +1 more source

Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus.

Journal of Investigative Dermatology, 2019
High-risk skin cancer is a rare, but severe, complication associated with discoid lupus erythematosus (DLE). Chronic scar, inflammation, UVR, and immunosuppressive medications are proposed explanations for this heightened skin cancer risk; however, the ...
Anniek Zaalberg, Sara Moradi Tuchayi, A. Ameri, K. Ngo, T. Cunningham, J. Eliane, Maia Livneh, T. Horn, I. Rosman, A. Musiek, M. Anadkat, S. Demehri   +11 more
semanticscholar   +1 more source

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

Lupus Science and Medicine, 2023
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj   +1 more source

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients with Extra‐Renal Systemic Lupus Erythematosus – A Systematic Review & Meta‐analysis

Arthritis Care &Research, Accepted Article.
Background Clinical response to Mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with SLE, particularly those with extra‐renal ...
Zahraa Qamhieh, Dalia Sriwi, Callie Saric, Tripti Singh, Christie M. Bartels, Shivani Garg   +5 more
wiley   +1 more source

Incidence of the autoimmune dermatosis in dogs and cats and retrospective study of 40 cases of discoid lupus erythematosus attended at the Dermatology Service of the College of Veterinary Medicine and Animal Science of UNESP – Botucatu /
Incidência das dermatopatias auto-imunes em cães e gatos e estudo retrospectivo de 40 casos de lupus eritematoso discóide atendidos no serviço de dermatologia da Faculdade de Medicina Veterinária e Zootecnia da UNESP – Botucatu

Semina: Ciências Agrárias, 2010
The objectives of this study were to do a survey of the autoimmune skin diseases and update the records regarding the occurrence of discoid lupus erythematosus in canine and feline populations attended at the Dermatology Service of the College of ...
Jéssica Correa Rodrigues, Fernanda Cristina de Oliveira, Jorge Piovesan Conti, Luiz Henrique de Araújo Machado, Mariana Isa Poci Palumbo   +4 more
doaj   +1 more source

Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program

Lupus Science and Medicine, 2019
Objective Epidemiological data for primary discoid lupus erythematosus (pDLE) remain limited, particularly for racial/ethnic populations in the USA. The Manhattan Lupus Surveillance Program (MLSP) is a population-based retrospective registry of cases ...
P. Izmirly, J. Buyon, H. M. Belmont, S. Sahl, I. Wan, J. Salmon, A. Askanase, J. Bathon, L. Geraldino‐Pardilla, Y. Ali, E. Ginzler, C. Putterman, C. Gordon, C. Helmick, Hilary B. Parton, .org, H. Michael   +16 more
semanticscholar   +1 more source

Coexistence of Discoid Lupus Erythematosus and Paraneoplastic Pemphigus: A Case Report and Literature Review

Clinical, Cosmetic and Investigational Dermatology, 2022
Wasin Saowaluksakul,1 Chutima Seree-aphinan,1 Suthinee Rutnin,1 Kochawan Boonyawat,2 Kumutnart Chanprapaph1 1Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; 2Division of ...
Saowaluksakul W, Seree-aphinan C, Rutnin S, Boonyawat K, Chanprapaph K   +4 more
doaj  

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane Kamen, Mariko Ishimori, Daniel J. Wallace, Christopher Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Eric W. Schaefer, Vernon M. Chinchilli, David R. Karp   +14 more
wiley   +1 more source